Patient-Derived Organoids Predict Treatment Response in Metastatic Colorectal Cancer

HUB Organoids is now part of the Life Science Business of Merck KGaA, Darmstadt, Germany

FOR RESEARCH USE ONLY. Unless otherwise stated in our catalog or other company documentation
accompanying the product(s), our products are intended for research use only and are not to be used
for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro
diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to
humans or animals.

Patient-Derived Organoids Predict Treatment Response in Metastatic Colorectal Cancer

Have any questions?